Compile Data Set for Download or QSAR
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 10686
TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559811BDBM559811(WO2022129953, Example 10)
Affinity DataIC50: 6.31nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559823BDBM559823(WO2022129953, Example 22)
Affinity DataIC50: 6.31nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559815BDBM559815(WO2022129953, Example 14)
Affinity DataIC50: 7.90nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559828BDBM559828(WO2022129953, Example 27)
Affinity DataIC50: 7.90nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559812BDBM559812(WO2022129953, Example 11)
Affinity DataIC50: 7.94nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559822BDBM559822(WO2022129953, Example 28 | WO2022129953, Example 2...)
Affinity DataIC50: 7.94nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559826BDBM559826(WO2022129953, Example 25)
Affinity DataIC50: 10nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559827BDBM559827(WO2022129953, Example 26)
Affinity DataIC50: 10nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559816BDBM559816(WO2022129953, Example 15)
Affinity DataIC50: 10nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559824BDBM559824(WO2022129953, Example 23)
Affinity DataIC50: 13nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559825BDBM559825(WO2022129953, Example 24)
Affinity DataIC50: 13nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559818BDBM559818(WO2022129953, Example 17)
Affinity DataIC50: 13nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559802BDBM559802(WO2022129953, Example 1)
Affinity DataIC50: 13nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559819BDBM559819(WO2022129953, Example 18)
Affinity DataIC50: 13nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559834BDBM559834(WO2022129953, Example 32)
Affinity DataIC50: 13nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559820BDBM559820(WO2022129953, Example 19)
Affinity DataIC50: 13nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559830BDBM559830(WO2022129953, Example 29)
Affinity DataIC50: 16nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559814BDBM559814(WO2022129953, Example 13)
Affinity DataIC50: 16nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559822BDBM559822(WO2022129953, Example 28 | WO2022129953, Example 2...)
Affinity DataIC50: 16nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559813BDBM559813(WO2022129953, Example 12)
Affinity DataIC50: 16nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559831BDBM559831(WO2022129953, Example 30)
Affinity DataIC50: 20nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559803BDBM559803(WO2022129953, Example 8 | WO2022129953, Example 2)
Affinity DataIC50: 20nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559817BDBM559817(WO2022129953, Example 16)
Affinity DataIC50: 20nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559835BDBM559835(WO2022129953, Example 33)
Affinity DataIC50: 25nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559832BDBM559832(WO2022129953, Example 31)
Affinity DataIC50: 25nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559804BDBM559804(WO2022129953, Example 3)
Affinity DataIC50: 25nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559821BDBM559821(WO2022129953, Example 20)
Affinity DataIC50: 100nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559810BDBM559810(WO2022129953, Example 9)
Affinity DataIC50: 398nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559806BDBM559806(WO2022129953, Example 5)
Affinity DataIC50: 501nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559805BDBM559805(WO2022129953, Example 4)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559807BDBM559807(WO2022129953, Example 6)
Affinity DataIC50: 5.01E+3nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559808BDBM559808(WO2022129953, Example 7)
Affinity DataIC50: 7.94E+3nMAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953

TargetReplicase polyprotein 1ab(2019-nCoV)
Heptares Therapeutics

WIPO
LigandChemical structure of BindingDB Monomer ID 559803BDBM559803(WO2022129953, Example 8 | WO2022129953, Example 2)
Affinity DataAssay Description:The activity of SARS-Cov-2 Mpro was determined in a Fluorescence Resonance Energy Transfer (FRET)-based enzymatic assay using FRET Substrate Dabcyl-K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022129953